Latest News

Ursula Weyrich succeeds Josef Puchta as Administrative Director of DKFZ

As of January 1, 2020, Ursula Weyrich will take over as Administrative Director of the German Cancer Research Center (DKFZ). Weyrich will succeed Josef Puchta, who reached the legal retirement age on November 30 after more than 23 years on the Management Board at DKFZ.

Deadline 5th January 2020

Apply now for the International PhD Program at the DKFZ!

Are you looking for excellent research opportunities for your PhD studies at the forefront of basic, epidemiological, computational or translational cancer research? Apply now!

We are asking for your support

Your Donation for Cancer Research
Latest News

Cell death or cancer growth: a question of cohesion

Activation of CD95, a receptor found on all cancer cells, triggers programmed cell death – or does the opposite, namely stimulates cancer cell growth. Scientists from the German Cancer Research Center (DKFZ) have now shown that the impact of CD95 activation depends on whether there are isolated cancer cells or three-dimensional structures. Individual cells are programmed to die following CD95 activation. In contrast, CD95 activation stimulates growth in clusters of cancer cells, for example in solid tumors. This finding points to new ways of specifically transforming growth-stimulating signals into cell death signals for the cancer cells.

Early detection of colon cancer

When is the right time for the follow-up colonoscopy?

For the early detection of colorectal cancer, patients with statutory health insurance are entitled to two colonoscopies. If the first examination does not reveal any abnormal findings, a follow-up after a period of ten years is recommended. Scientists at the German Cancer Research Center are now systematically investigating when and how often tissue lesions are detected during the follow up colonoscopy. Their conclusion: The ten-year period is usually reasonable. It is not yet possible to say whether and for which group of people the follow-up colonoscopy can be postponed even further.


Meyenburg Prize 2019 for outstanding research on leukemia

The Meyenburg Prize 2019, which carries prize money of 50,000 euros, goes to Benjamin L. Ebert from the Dana-Farber Cancer Institute in Boston for his outstanding research results on the pathogenesis and treatment of leukemia. The award ceremony will take place on Thursday, November 7, 2019 as part of a symposium at the German Cancer Research Center.


Search for research topic

DKTK Tübingen

Bispecific antibody to be tested for treatment of prostate cancer

Prostate carcinoma is the most common type of cancer in men. If the tumor metastasizes, it is not curable by established treatment modalities.. The German Cancer Consortium (DKTK) is launching a clinical phase I study in November to test a bispecific antibody with the aim of achieving a significant improvement for patientswith this type of cancer. The bispecific antibody has been developed in Tübingen. The study is supported by the Helmholtz Validation Fund and the DKTK.

Latest News

Protein misfolding as a risk marker for Alzheimer’s disease – up to 14 years before the diagnosis

In symptom-free individuals, the detection of misfolded amyloid-β protein in the blood indicated a considerably higher risk of Alzheimer's disease – up to 14 years before a clinical diagnosis was made. Amyloid-β folding proved to be superior to other risk markers evaluated, as shown by scientists from the German Cancer Research Center (DKFZ), Ruhr University Bochum (RUB), the Saarland Cancer Registry, and the Network Aging Research at Heidelberg University.

Latest News

HPV vaccination rate of 70 percent is possible and reasonable

Germany needs to agree on a target for the HPV vaccination rate in order to protect more people against cancer caused by human papillomavirus (HPV). Representatives from the health sector, research, and politics attended a Round Table to Eradicate HPV-Related Cancer to achieve this goal in response to an invitation from the German Cancer Research Center (DKFZ) and the Preventa Foundation. The participants agreed on the goal of achieving a vaccination rate of at least 70 percent among 15-year-olds across the country within the next five years. School vaccinations, invitation processes, vaccination consultations, uniform prescription processes throughout Germany, and a centrally managed information campaign can help achieve this goal.

Latest News

Familial risk of colorectal cancer: the genes only tell part of the story

On the basis of a current epidemiological study, scientists at the German Cancer Research Center (DKFZ) conclude that the role of genes has been overestimated in patients with a higher familial risk of colorectal cancer. Other risk factors such as family dietary habits presumably have a greater impact that previously assumed. This will have implications for future calculations of individual risk and for the ensuing recommendations.

DKFZ - A Video

to top